Time of onset and factors associated with delayed response post intradetrusor injection of onabotulinumtoxin a in patients with neurogenic and idiopathic overactive bladder syndrome
Objective: The objective of this study was to determine risk factors for delayed response in patients with neurogenic and idiopathic overactive bladder (OAB) after intradetrusor onabotulinumtoxin A injection. Subjects and Methods: This is a retrospective study that included 87 patients who underwent...
Main Authors: | Tariq Faisal Al-Shaiji, Rawan Jamal Al-Yousef, Ahmed Refat EL-Nahas, Awad Thahir Awad, Meshari Falah Almutairi, Abdullatif Ebrahim Al-Terki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Urology Annals |
Subjects: | |
Online Access: | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2023;volume=15;issue=2;spage=133;epage=137;aulast=Al-Shaiji |
Similar Items
-
Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience
by: Vladimír Šámal, et al.
Published: (2020-03-01) -
Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
by: Marcio Augusto Averbeck
Published: (2021-02-01) -
Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01) -
Botulinum Toxin A in the treatment of frostbite sequelae – results from a blinded, early-phase, comparative trial
by: Arne Johan Norheim, et al.
Published: (2023-12-01) -
Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions
by: Hend D. Gamil, et al.
Published: (2020-07-01)